HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antonio Cano Selected Research

Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)

2/2022Histological Grade and Tumor Stage Are Correlated with Expression of Receptor Activator of Nuclear Factor Kappa b (Rank) in Epithelial Ovarian Cancers.
1/2020Differential expression of receptor activator of nuclear factor kappa B in healthy endometrium, ovarian endometrioma, and endometrioid ovarian cancer.
6/2018Receptor Activator of Nuclear Factor Kappa B (RANK) and Clinicopathological Variables in Endometrial Cancer: A Study at Protein and Gene Level.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Antonio Cano Research Topics

Disease

11Neoplasms (Cancer)
02/2022 - 05/2003
11Breast Neoplasms (Breast Cancer)
03/2021 - 04/2004
7Cardiovascular Diseases (Cardiovascular Disease)
09/2020 - 04/2004
6Atherosclerosis
06/2021 - 01/2007
6Osteoporosis
10/2020 - 08/2014
4Endometriosis
02/2022 - 08/2003
4Osteoporotic Fractures
01/2021 - 01/2011
3Metabolic Syndrome (Dysmetabolic Syndrome X)
04/2022 - 06/2020
3Insulin Resistance
04/2022 - 11/2010
3Carcinogenesis
02/2022 - 01/2016
3Chronic Disease (Chronic Diseases)
06/2021 - 08/2012
3COVID-19
10/2020 - 04/2020
3Multiple Sclerosis
01/2019 - 01/2016
3Frailty
12/2018 - 01/2017
3Coronary Disease (Coronary Heart Disease)
11/2012 - 12/2005
2Urinary Incontinence
06/2021 - 03/2018
2Atrophy
06/2021 - 10/2012
2Obesity
10/2020 - 06/2020
2Postmenopausal Osteoporosis
01/2019 - 01/2018
2Stress Urinary Incontinence
03/2018 - 02/2013
2Hip Fractures (Intertrochanteric Fractures)
01/2017 - 01/2011
2Bone Resorption
04/2015 - 04/2009
2Stroke (Strokes)
11/2012 - 01/2007
1Pain (Aches)
02/2022
1Ovarian Epithelial Carcinoma
02/2022
1Type 2 Diabetes Mellitus (MODY)
02/2022
1Inflammation (Inflammations)
10/2021
1Migraine Disorders (Migraine)
07/2021
1Urinary Tract Infections (Urinary Tract Infection)
06/2021
1Osteoarthritis
01/2021
1Wounds and Injuries (Trauma)
01/2021
1Urge Urinary Incontinence (Urge Incontinence)
01/2021
1Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
10/2020
1Psychological Sexual Dysfunctions (Sexual Arousal Disorder)
05/2020
1Dyslipidemias (Dyslipidemia)
05/2020
1Hypertriglyceridemia
05/2020
1Pneumonia (Pneumonitis)
04/2020
1Female Infertility
01/2020
1Hypothyroidism
04/2019
1Autoimmune Thyroiditis (Lymphomatous Thyroiditis)
04/2019
1Malnutrition (Nutritional Deficiencies)
12/2018
1Lymphopenia (Lymphocytopenia)
12/2018
1Relapsing-Remitting Multiple Sclerosis
12/2018
1Endometrial Neoplasms (Endometrial Cancer)
06/2018

Drug/Important Bio-Agent (IBA)

15Estrogens (Estrogen)FDA Link
04/2022 - 04/2004
12Hormones (Hormone)IBA
09/2021 - 09/2005
5LipidsIBA
04/2022 - 11/2010
4Pharmaceutical PreparationsIBA
02/2022 - 08/2012
4Selective Estrogen Receptor Modulators (SERM)IBA
11/2018 - 04/2004
4Estrogen ReceptorsIBA
10/2018 - 03/2003
4Estradiol (Delestrogen)FDA LinkGeneric
05/2010 - 09/2005
3AndrogensIBA
04/2022 - 10/2020
3Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA
02/2022 - 06/2018
3Biomarkers (Surrogate Marker)IBA
10/2021 - 11/2015
3LigandsIBA
09/2021 - 01/2016
3Progestins (Progestagens)IBA
09/2021 - 01/2016
3MicroRNAs (MicroRNA)IBA
01/2021 - 11/2015
3TamoxifenFDA LinkGeneric
11/2018 - 03/2003
3Raloxifene Hydrochloride (Evista)FDA Link
12/2005 - 02/2003
2Messenger RNA (mRNA)IBA
02/2022 - 06/2018
2mahuang-tangIBA
07/2020 - 11/2018
2Fingolimod Hydrochloride (FTY720)FDA Link
01/2019 - 12/2018
2Contraceptive Agents (Contraceptives)IBA
11/2018 - 11/2018
2Proteins (Proteins, Gene)FDA Link
06/2018 - 01/2011
2CalciumIBA
01/2018 - 02/2015
2CD40 Ligand (CD40L)IBA
02/2016 - 06/2008
2AntioxidantsIBA
07/2011 - 05/2003
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2021
1CytokinesIBA
09/2021
1erenumabIBA
07/2021
1LubricantsIBA
06/2021
1SteroidsIBA
05/2021
1Dopamine Receptors (Dopamine Receptor)IBA
03/2021
1onabotulinum toxin AIBA
01/2021
1Indoleacetic Acids (Auxin)IBA
01/2021
1Olive OilIBA
10/2020
1Insulin (Novolin)FDA Link
10/2020
1coactivator-associated arginine methyltransferase 1IBA
10/2020
1Testosterone (Sustanon)FDA Link
05/2020
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
05/2020
1oxidized low density lipoproteinIBA
05/2020
1ProlactinIBA
01/2020
1AntralIBA
01/2020
1IodineIBA
04/2019
1Diphosphonates (Bisphosphonates)IBA
01/2019
1Dimethyl FumarateIBA
01/2019
1Sphingosine-1-Phosphate ReceptorsIBA
12/2018
1hydroxide ionIBA
10/2018
1Vitamin DFDA LinkGeneric
10/2018
1Complementary DNA (cDNA)IBA
06/2018

Therapy/Procedure

11Therapeutics
06/2021 - 02/2003
2Mediterranean Diet
04/2022 - 09/2020
2Drug Therapy (Chemotherapy)
10/2018 - 09/2014
2Suburethral Slings (Tension-Free Vaginal Tape)
03/2018 - 02/2013
2Ovariectomy (Oophorectomy)
04/2015 - 08/2014
2Hormone Replacement Therapy (Therapy, Hormone Replacement)
04/2004 - 02/2003
1Injections
01/2021
1Hormonal Contraception
07/2020
1Transplantation
04/2020
1Polypharmacy
12/2018